Hideki Asaoku

5.9k total citations · 1 hit paper
102 papers, 3.9k citations indexed

About

Hideki Asaoku is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Hideki Asaoku has authored 102 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hematology, 41 papers in Oncology and 40 papers in Molecular Biology. Recurrent topics in Hideki Asaoku's work include Multiple Myeloma Research and Treatments (49 papers), Lymphoma Diagnosis and Treatment (18 papers) and Glycosylation and Glycoproteins Research (12 papers). Hideki Asaoku is often cited by papers focused on Multiple Myeloma Research and Treatments (49 papers), Lymphoma Diagnosis and Treatment (18 papers) and Glycosylation and Glycoproteins Research (12 papers). Hideki Asaoku collaborates with scholars based in Japan, Greece and Egypt. Hideki Asaoku's co-authors include Osamu Tanabe, Atsushi Kuramoto, Michio Kawano, Hideo Tanaka, Koji Iwato, Tetsuya Taga, Tadashi Matsuda, Bo Tang, Yasuhiro Horii and Toshio Hirano and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Blood.

In The Last Decade

Hideki Asaoku

98 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1988 1.4k citations Michio Kawano, Toshio Hirano et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hideki Asaoku Japan	28	1.7k	1.6k	1.4k	882	703	102	3.9k
Stefan Hohaus Italy	39	1.5k 0.9×	1.4k 0.8×	1.4k 1.0×	913 1.0×	1.0k 1.4×	167	4.2k
Marco Gobbi Italy	33	1.9k 1.1×	1.3k 0.8×	1.0k 0.7×	969 1.1×	644 0.9×	171	3.9k
Klaus Beiske Norway	35	588 0.4×	1.2k 0.8×	938 0.7×	1.3k 1.5×	598 0.9×	119	4.1k
Aaron P. Rapoport United States	32	1.1k 0.6×	2.1k 1.3×	1.2k 0.9×	703 0.8×	491 0.7×	162	3.8k
Chihiro Shimazaki Japan	33	2.4k 1.4×	1.2k 0.8×	1.5k 1.1×	659 0.7×	594 0.8×	213	4.0k
Frederic I. Preffer United States	43	1.6k 0.9×	2.0k 1.3×	2.0k 1.4×	2.3k 2.6×	905 1.3×	112	7.0k
Dina Ben‐Yehuda Israel	35	1.7k 1.0×	1.3k 0.8×	2.1k 1.5×	579 0.7×	1.4k 1.9×	124	4.8k
Norio Komatsu Japan	44	2.8k 1.7×	1.2k 0.8×	2.6k 1.9×	1.4k 1.5×	469 0.7×	384	6.7k
Júlia Almeida Spain	42	1.5k 0.9×	1.0k 0.7×	1.2k 0.9×	2.3k 2.6×	1.3k 1.9×	132	4.9k
Avichai Shimoni Israel	41	3.6k 2.2×	2.9k 1.8×	1.1k 0.8×	2.1k 2.4×	685 1.0×	252	6.9k

Countries citing papers authored by Hideki Asaoku

Since Specialization

Citations

This map shows the geographic impact of Hideki Asaoku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Asaoku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Asaoku more than expected).

Fields of papers citing papers by Hideki Asaoku

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Asaoku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Asaoku. The network helps show where Hideki Asaoku may publish in the future.

Co-authorship network of co-authors of Hideki Asaoku

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Asaoku. A scholar is included among the top collaborators of Hideki Asaoku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Asaoku. Hideki Asaoku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takizawa, Jun, Ritsuro Suzuki, Koji Izutsu, et al.. (2024). Characteristics of chronic lymphocytic leukemia in Japan: Comprehensive analysis of the CLLRSG-01 study. International Journal of Hematology. 119(6). 686–696. 2 indexed citations

Sunami, Kazutaka, Shin‐ichi Fuchida, Kenshi Suzuki, et al.. (2022). Anti‐CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs study. Hematological Oncology. 41(3). 442–452. 1 indexed citations

Ozaki, Shuji, Hiroshi Handa, Takayuki Saitoh, et al.. (2019). Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma. Annals of Hematology. 98(7). 1703–1711. 9 indexed citations

Aoki, Sadao, Jun Takizawa, Naoya Nakamura, et al.. (2016). CD13 positive chronic lymphocytic leukemia-A distinct subset of CLL-. 57(9). 1502. 1 indexed citations

Sairaku, Akinori, et al.. (2016). Prognostic Significance of New-Onset Atrial Fibrillation in Patients With Non-Hodgkin's Lymphoma Treated With Anthracyclines. The American Journal of Cardiology. 118(9). 1386–1389. 32 indexed citations

Yoshida, Noriaki, Yoshiaki Kuroda, Yuta Katayama, et al.. (2013). Clinical Significance of sIL-2R Levels in B-Cell Lymphomas. PLoS ONE. 8(11). e78730–e78730. 46 indexed citations

Tanaka, Kimio, et al.. (2012). Higher involvement of subtelomere regions for chromosome rearrangements in leukemia and lymphoma and in irradiated leukemic cell line. Indian Journal of Science and Technology. 5(1). 1801–1811. 46 indexed citations

Yamamura, Kazuhiko, et al.. (2012). Two Cases of Angioimmunoblastic T-cell Lymphoma Presenting with a Skin Eruption. The Nishinihon Journal of Dermatology. 74(4). 399–404.

Shimada, Kazuyuki, Takuhei Murase, Kosei Matsue, et al.. (2010). Central nervous system involvement in intravascular large B‐cell lymphoma: A retrospective analysis of 109 patients. Cancer Science. 101(6). 1480–1486. 80 indexed citations

10.

Nojima, Masanori, Reo Maruyama, Hiroshi Yasui, et al.. (2009). Genomic Screening for Genes Silenced by DNA Methylation Revealed an Association between RASD1 Inactivation and Dexamethasone Resistance in Multiple Myeloma. Clinical Cancer Research. 15(13). 4356–4364. 53 indexed citations

11.

Iqbal, Mohd S., Ken‐ichiro Otsuyama, Karim Shamsasenjan, et al.. (2009). Constitutively lower expressions of CD54 on primary myeloma cells and their different localizations in bone marrow. European Journal Of Haematology. 83(4). 302–312. 11 indexed citations

12.

Abroun, Saeid, Ken‐ichiro Otsuyama, Karim Shamsasenjan, et al.. (2008). Galectin‐1 supports the survival of CD45RA(−) primary myeloma cells in vitro. British Journal of Haematology. 142(5). 754–765. 28 indexed citations

13.

Sakai, Akira, Yoshiaki Kuroda, Yuta Katayama, et al.. (2007). Connective tissue growth factor is an indicator of bone involvement in multiple myeloma, but matrix metalloproteinase‐9 is not. British Journal of Haematology. 139(1). 41–50. 14 indexed citations

14.

Katayama, Yuta, Akira Sakai, Naohide Oue, et al.. (2003). A possible role for the loss of CD27–CD70 interaction in myelomagenesis. British Journal of Haematology. 120(2). 223–234. 28 indexed citations

15.

Myoken, Yoshinari, Tatsumi Sugata, Yasunori Fujita, et al.. (2002). Fatal necrotizing stomatitis due to Trichoderma longibrachiatum in a neutropenic patient with malignant lymphoma: a case report. International Journal of Oral and Maxillofacial Surgery. 31(6). 688–691. 31 indexed citations

16.

Nakamura, Shôji, Akira Yokota, T. Yoshino, et al.. (2000). びまん性大細胞型B細胞リンパ腫(DLBCL)における血清可溶性インターロイキン2受容体(sIL-2R)レベル:重要な予後因子. Annals of Oncology. 11. 103. 2 indexed citations

17.

Yokota, Akira, Shinji Nakamura, T. Yoshino, et al.. (1999). High levels of serum CD44 are correlated with poor prognosis in malignant lymphoma.. Blood. 94(10). 511. 1 indexed citations

18.

Kumaravel, T. S., Hideki Asaoku, Hiroo Dohy, et al.. (1999). Protein Expression of Cell Cycle Regulator, p27^Kip1, Correlates with Histopathological Grade of Non‐Hodgkin's Lymphoma. Japanese Journal of Cancer Research. 90(11). 1262–1269. 8 indexed citations

19.

Sakai, Akira, Kenji Oda, Hideki Asaoku, et al.. (1998). Expressions of p53 and PCNA do not correlate with the international index or early response to chemotherapy in non-Hodgkin's Lymphoma. American Journal of Hematology. 58(1). 42–48. 4 indexed citations

20.

Kawano, Michio, Toshio Hirano, Tadashi Matsuda, et al.. (1988). Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature. 332(6159). 83–85. 1414 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact